Want to join a small community of investors looking for the next big winners in 2023?

These 3 Stocks are potential sky-high performers you should be watching heading into Monday.

Click Here for Names & Ticker Symbols.

Bryan Giraudo Biography and Net Worth

CFO of Gossamer Bio

Mr. Giraudo is the Chief Financial Officer of Gossamer Bio. Previously, he was Senior Managing Director at LEERINK Partners, where he was responsible for LEERINK’s Western North America and Asia life sciences investment banking practice. Prior to joining LEERINK Partners in 2009, Bryan was a Managing Director in Merrill Lynch’s Global Healthcare Investment Banking Group. Bryan received his B.A. from Georgetown University.

What is Bryan Giraudo's net worth?: The estimated net worth of Bryan Giraudo is at least $156,857.55 as of April 4th, 2023. Mr. Giraudo owns 125,990 shares of Gossamer Bio stock worth more than $156,858 as of May 30th. This net worth approximation does not reflect any other assets that Mr. Giraudo may own. Learn More about Bryan Giraudo's net worth.
How do I contact Bryan Giraudo?: The corporate mailing address for Mr. Giraudo and other Gossamer Bio executives is 3013 SCIENCE PARK, SAN DIEGO CA, 92121. Gossamer Bio can also be reached via phone at (858) 684-1300 and via email at [email protected]. Learn More on Bryan Giraudo's contact information.
Has Bryan Giraudo been buying or selling shares of Gossamer Bio?: During the last ninety days, Bryan Giraudo has bought $56,100.00 in shares of Gossamer Bio stock. Most recently, on Tuesday, April 4th, Bryan Giraudo bought 55,000 shares of Gossamer Bio stock. The stock was acquired at an average cost of $1.02 per share, with a total value of $56,100.00. Following the completion of the transaction, the chief financial officer now directly owns 125,990 shares of the company's stock, valued at $128,509.80. Learn More on Bryan Giraudo's trading history.
Who are Gossamer Bio's active insiders?: Gossamer Bio's insider roster includes Laura Carter (Insider), Bryan Giraudo (CFO), and Luisa Salter-Cid (Insider). Learn More on Gossamer Bio's active insiders.
Are insiders buying or selling shares of Gossamer Bio?: During the last year, Gossamer Bio insiders bought shares 8 times. They purchased a total of 892,182 shares worth more than $1,952,701.28. During the last year, insiders at the sold shares 6 times. They sold a total of 33,812 shares worth more than $216,121.25. The most recent insider tranaction occured on April, 4th when CFO Bryan Giraudo bought 55,000 shares worth more than $56,100.00. Insiders at Gossamer Bio own 8.3% of the company. Learn More about insider trades at Gossamer Bio.
Information on this page was last updated on 4/4/2023.

Bryan Giraudo Insider Trading History at Gossamer Bio

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/4/2023	Buy	55,000	$1.02	$56,100.00	125,990
3/20/2023	Buy	50,000	$0.97	$48,500.00	70,990
7/15/2022	Buy	13,869	$7.21	$99,995.49	20,990
3/23/2021	Sell	5,490	$9.48	$52,045.20	109,889
10/14/2020	Buy	3,000	$10.01	$30,030.00
6/23/2020	Buy	2,000	$12.96	$25,920.00
9/26/2019	Buy	1,121	$16.78	$18,810.38
5/30/2019	Buy	1,000	$18.70	$18,700.00
2/12/2019	Buy	6,000	$16.00	$96,000.00

Bryan Giraudo Buying and Selling Activity at Gossamer Bio

Gossamer Bio Company Overview

Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. The company was founded by Faheem Hasnain and Sheila Gujrathi on October 25, 2015 and is headquartered in San Diego, CA.

Today's Range

Now: $1.26

$1.23

$1.31

50 Day Range

MA: $1.22

$0.98

$1.53

2 Week Range

Now: $1.26

$0.91

$15.20

Volume

1,423,451 shs

Average Volume

3,205,280 shs

Market Capitalization

$120.25 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.2

3 Potential Sky-High Performers

From Weekly Investor Alerts | Ad

>>>